Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
ALKS 7119
/
Alkermes
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
||
||||||||
ALKS 7119
/
Alkermes
Clinical, Journal:
Pharmacological profile of ALKS 7119, an investigational compound evaluated for the treatment of neuropsychiatric disorders, in healthy volunteers.
(Pubmed Central) - May 19, 2022
In line with ALKS 7119's in vitro pharmacological profile, the clinical profile observed in this study is most comparable to SERT inhibition.